We are live on ! Find out more
PHXM

PHAXIAM Therapeutics S.A.. American Depositary Shares

Delisted

PHXM was delisted on the 8th of March, 2024.

1 hedge funds and large institutions have $1K invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

50% less capital invested

Capital invested by funds: $2K → $1K (-$1K)

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
ADL
1
Asset Dedication LLC
California
$1K

PHXM Hedge Fund Activity: Q1 2024 in Review

1 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q1 2024, worth a combined $1K — down 50% from $2K a quarter earlier.

Fund positioning in PHXM was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $1K of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q1 2024, down 50% quarter-over-quarter.
  • 0 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q1 2024 and 0 closed out.

Based on aggregated 13F filings for Q1 2024.